K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomasDong-Anh Khuong-Quang, Cynthia Hawkins, Pawel Buczkowicz et al.|Acta Neuropathologica|2012Cited by 1k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair DeficiencyÉric Bouffet, Uri Tabori, Samina Afzal et al.|Journal of Clinical Oncology|2016Cited by 867
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in MedulloblastomaNataliya Zhukova, Rebecca M. Hill, Vijay Ramaswamy et al.|Journal of Clinical Oncology|2013Cited by 488
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG RegistriesLindsey M. Hoffman, Dominik Sturm, Sophie E. M. Veldhuijzen van Zanten et al.|Journal of Clinical Oncology|2018Cited by 433
Clonal selection drives genetic divergence of metastatic medulloblastomaXiaochong Wu, Michael D. Taylor, Paul A. Northcott et al.|Nature|2012Cited by 412